Search
Close this search box.

Investor
Relations

Inspire. Grow. Care.

Explore our Deck

Find the company overview and discover with us exciting scientific developments and business opportunities.

SEC Filings

From the CEO's desk:
Vertical integration

Periodic updates and perspectives on various aspects of our business.

Our Research

IGC-AD1

Is designed to target neuroinflammation, potentially stabilize CB1r function and address neurotransmitter imbalances, all hallmarks associated with agitation in Alzheimer Dementia

TGR-63

A small molecule designed to break down plaque formation in the brain, exhibiting outstanding biocompatibility, the ability to breach the blood–brain barrier, and pre-clinical behavioral efficacy.

A.I.

To mine the depths of decades-worth of Alzheimer’s research, bringing to light novel insights and pioneering advanced treatments faster than ever for a healthier elderliness.

Science

IGC Pharma is actively building a portfolio of both plant-derived and manufactured molecules that can address multiple areas of unmet medical needs.

Locations

Our company has operations in different countries
manufacturing vertical and R&D capabilities.